We were able to reduce the circulation-supporting medication and we saw decreasing lacatate levels and the patient was more stable.
Dr. Gry Dahle talks about CytoSorb.
In my experience the vasopressor doses decreased, biomarkers of sepsis (…) and the inflammatory response as well as multiple organ function improved.